SLC2A3 and gastric cancer: It was also found that miRNA-129-5p could inhibit the uptake and consumption of glucose by gastric cancer cells by targeting the 3′-UTR of SLC2A3, and that MAPK signaling pathway was involved in the miR-129-5p/SLC2A3 axis37.